LTFU for All Cell and Gene Therapy Studies

Starting soon

Conditions studied: Hepatocellular Carcinoma, Prostate Cancer

In brief

Master LTFU study will monitor the long-term safety and tolerability of cell or gene therapy study participants from AstraZeneca for up to 15 years post last cell or gene therapy treatment.

Key facts

Study ID

NCT06194461

Run by

AstraZeneca

People needed

64

Starts

2025-09-17

Expected to finish

2041-11-29

Last updated by the study team

2025-06-27

Who can join

Age: 18 and older, up to 130. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• The participant has received a cell or gene therapy in another AstraZeneca protocol.
• Provision of signed and dated, written informed consent before any study-specific procedures.

You may not qualify if…

• Not applicable

Where it is running

• Research Site — Phoenix, Arizona, United States
• Research Site — Duarte, California, United States
• Research Site — Orange, California, United States
• Research Site — San Francisco, California, United States
• Research Site — Washington D.C., District of Columbia, United States
• Research Site — Jacksonville, Florida, United States
• Research Site — Tampa, Florida, United States
• Research Site — Atlanta, Georgia, United States
• Research Site — Westwood, Kansas, United States
• Research Site — Rochester, Minnesota, United States
• Research Site — St Louis, Missouri, United States
• Research Site — Hackensack, New Jersey, United States
• Research Site — New York, New York, United States
• Research Site — Columbus, Ohio, United States
• Research Site — Portland, Oregon, United States
• Research Site — Philadelphia, Pennsylvania, United States
• Research Site — Pittsburgh, Pennsylvania, United States
• Research Site — Houston, Texas, United States
• Research Site — East Melbourne, Australia
• Research Site — Kashiwa, Japan
• Research Site — Kyoto, Japan
• Research Site — Osakasayama-shi, Japan
• Research Site — Seoul, South Korea
• Research Site — Seoul, South Korea
• Research Site — Seoul, South Korea

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.